Taysha Gene Therapies, Inc. Business Finance Contracts & Agreements
11 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Loan Agreements (1)
- Purchase Agreements (2)
- Registration Rights Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (3)
- Warrant Agreements (1)
- Form of Securities Purchase Agreement, dated August 14, 2023, by and among Taysha Gene Therapies, Inc. and the Purchasers (Filed With SEC on August 14, 2023)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on August 14, 2023)
- Registration Rights Agreement, by and between the Company and Astellas, dated October 21, 2022 (Filed With SEC on October 31, 2022)
- Securities Purchase Agreement, by and between the Company and Astellas, dated October 21, 2022 (Filed With SEC on October 31, 2022)
- Underwriting Agreement by and between Taysha Gene Therapies, Inc. and Goldman Sachs & Co. LLC, dated October 26, 2022 (Filed With SEC on October 27, 2022)
- Loan and Security Agreement, dated August 12, 2021, by and among the Company, the lenders party thereto from time to time and Silicon Valley Bank, as administrative agent and... (Filed With SEC on August 16, 2021)
- Description of the Companys Common Stock (Filed With SEC on March 3, 2021)
- Form of Underwriting Agreement (Filed With SEC on September 18, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on September 17, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 17, 2020)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated July 2, 2020 (Filed With SEC on September 2, 2020)
